| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |


From the Department of Nephrology and Transplantation,*
Kings College, University of London, Guys Hospital, London, United
Kingdom; and the Second Department of Internal
Medicine,
Nagasaki University School of
Medicine, Nagasaki, Japan
Recent evidence has implicated complement in renal transplant
injury and identified the kidney as a source of complement components.
We therefore investigated the local gene expression of complement
component C3, pivotal to complement activation pathways and a
mediator of inflammatory injury, in a rat renal transplant
model. By reverse transcriptase-polymerase chain reaction, the
expression of C3 mRNA increased in two phases. The first phase
coincided with post-ischemic injury over 2 days post-transplantation
and was localized by in situ hybridization to vessels
and glomerular mesangial cells in allogeneic and syngeneic (control)
kidney transplants. In allografts only, a second phase was
found in tubular epithelial cells, glomerular parietal
cells, vessel walls and some infiltrating cells, which
peaked on day 4 together with rapid influx of leukocytes,
tubule cell damage, the induction of interleukin-2 and
interferon-
mRNA, and the up-regulation of tumor necrosis
factor-
and interleukin-1ß mRNA in the graft. In
vitro studies showed that interleukin-2 and interferon-
up-regulate C3 production in renal tubule cells. We conclude that
post-ischemic injury led to transient up-regulation of glomerular
expression of C3 mRNA. Subsequent cellular rejection was associated
with tubulointerstitial/glomerular parietal cell expression of C3 mRNA.
This differential expression of local C3, immediately
post-transplant or associated with acute rejection, may have
implications for putative therapeutic complement inhibition in clinical
transplantation.
This article has been cited by other articles:
![]() |
G Ferraccioli and G Romano Renal interstitial cells, proteinuria and progression of lupus nephritis: new frontiers for old factors Lupus, June 1, 2008; 17(6): 533 - 540. [Abstract] [PDF] |
||||
![]() |
D. Liu, J.-Y. Zhu, and Z.-X. Niu Molecular Structure and Expression of Anthropic, Ovine, and Murine Forms of Complement Receptor Type 2 Clin. Vaccine Immunol., June 1, 2008; 15(6): 901 - 910. [Full Text] [PDF] |
||||
![]() |
H. Wang, J. Arp, W. Liu, S. J. Faas, J. Jiang, D. R. Gies, S. Ramcharran, B. Garcia, R. Zhong, and R. P. Rother Inhibition of Terminal Complement Components in Presensitized Transplant Recipients Prevents Antibody-Mediated Rejection Leading to Long-Term Graft Survival and Accommodation J. Immunol., October 1, 2007; 179(7): 4451 - 4463. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Brown, E. Kondeatis, R. W. Vaughan, S. P. Kon, C. K.T. Farmer, J. D. Taylor, X. He, A. Johnston, C. Horsfield, B. J.C. Janssen, et al. Influence of donor C3 allotype on late renal-transplantation outcome. N. Engl. J. Med., May 11, 2006; 354(19): 2014 - 2023. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lin, W. Zhou, C. A. Farrar, R. E.G. Hargreaves, N. S. Sheerin, and S. H. Sacks Deficiency of C4 from Donor or Recipient Mouse Fails to Prevent Renal Allograft Rejection Am. J. Pathol., April 1, 2006; 168(4): 1241 - 1248. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Li, H. Patel, C. A. Farrar, R. E.G. Hargreaves, S. H. Sacks, and W. Zhou Complement Activation Regulates the Capacity of Proximal Tubular Epithelial Cell to Stimulate Alloreactive T Cell Response J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2414 - 2422. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Pratt, M. E. Jones, J. Dong, W. Zhou, P. Chowdhury, R. A. G. Smith, and S. H. Sacks Nontransgenic Hyperexpression of a Complement Regulator in Donor Kidney Modulates Transplant Ischemia/Reperfusion Damage, Acute Rejection, and Chronic Nephropathy Am. J. Pathol., October 1, 2003; 163(4): 1457 - 1465. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nakashima, Z. Qian, S. Rahimi, B. A. Wasowska, and W. M. Baldwin III Membrane Attack Complex Contributes to Destruction of Vascular Integrity in Acute Lung Allograft Rejection J. Immunol., October 15, 2002; 169(8): 4620 - 4627. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |